Zurampic Reviewers
FDA staff who participated in the review of the URAT1 inhibitor for treatment of hyperuricemia associated with gout.
More from Product Reviews
More from Pink Sheet
• By
George Tidmarsh has extensive experience in the biopharmaceutical industry and led several drugs to FDA approval.
• By
Innovator drug advocates argued that the number of patents asserted by industry is not too dissimilar to other fields. But should drugs be compared to golf balls?
• By
Testimony during a July 21 ‘expert panel’ could help justify stronger warnings across the class about potential adverse effects on mother and baby. Panelists ranged from clinicians who said depression during pregnancy should be treated, to those who said sadness has been “medicalized."